AstraZeneca Pharma India Limited informed that at the Company's Annual General Meeting held on August 8, 2022, the Shareholders have approved the appointment of Ms. Shilpa Shridhar Divekar, as an Independent Director for a term of 5 years with effect from December 29, 2021 till December 28, 2026. Ms. Shilpa Shridhar Divekar has over two decades of rich experience across consulting and food & agriculture sectors. As part of her leadership journey, she led Regional Business Strategy for Asia Pacific and coled Global Smallholder Strategy at Bayer CropScience.

She served as the Chief Executive Officer of Monsanto India from 2014 to 2018 and was also responsible as Managing Director of the publicly listed entity in India. Prior to her 12 years stint at Bayer and Monsanto, she was the Head of Strategy & Business Development for Bunge India, a US headquartered multinational involved in oilseeds, commodity trading & foods.